• Email Us: [email protected]
  • Contact Us: +1 718 618 4351
  • Skip to content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Chevron braces for activist challenge; meets Engine No.1 representatives- WSJ

September 3, 2021 by David Barret Leave a Comment

September 3, 2021

(Reuters) – Chevron Corp is preparing to defend itself against a potential challenge from activist investors and met with representatives of the pro-environment fund at the center of similar events at Exxon earlier this year, the Wall Street Journal reported on Friday, citing people familiar with the matter.

Chevron shared some of its plans to cut carbon emissions during talks with the Engine No. 1 fund, the report said. The talks were described as cordial and the activist fund gave no indication that it would pursue a campaign against the company, the report added.

Engine No. 1 is weighing the option of launching a second campaign against a major oil company, the report said, after the fund managed to get three nominees elected to Exxon’s board in June.

Engine No. 1 hasn’t made any decision about another campaign, the report added.

The fund and Chevron did not immediately respond to a Reuters request for comment.

(Reporting by Rithika Krishna in Bengaluru; Editing by Shailesh Kuber)

Source Link Chevron braces for activist challenge; meets Engine No.1 representatives- WSJ

Related posts:

  1. Voice chat is coming to Roblox
  2. PDFs are finally set to be less annoying on Microsoft Edge
  3. Oil rises on economic recovery hopes, weaker dollar
  4. Tennis – Kerber sails through to set up battle of former champions

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar


  • Home
  • All Reports
  • About Us
  • Contact Us
  • +1 718 618 4351
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2022 · Medical Market Report. All Rights Reserved.

Go to mobile version